Work

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

Year: 2017
Type: review
Abstract: CK2 genes are overexpressed in many human cancers, and most often overexpression is associated with worse prognosis. Site-specific expression in mice leads to cancer development (e.g., breast, lymphoma) indicating the oncogenic nature of CK2. CK2 is involved in many key aspects of cancer including inhibition of apoptosis, modulation of signaling pathways, DNA damage response, and cell cycle regulation. A number of CK2 inhibitors are now available and have been shown to have activity against various cancers in vitro and in pre-clinical models. Some of these inhibitors are now undergoing exploration in clinical trials as well. In this review, we will examine some of the major cancers in which CK2 inhibition has promise based on in vitro and pre-clinical studies, the proposed cellular and signaling mechanisms of anti-cancer activity by CK2 inhibitors, and the current or recent clinical trials using CK2 inhibitors.
Institution: Boston University
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W2581414232
FWCI: 1.988
Cites: 202
Cited by: 194
Related to: 10